When cystic fibrosis hits your lungs hard, hit back. Everything you need to know about getting your lungs back into shape is ...
Vertex Pharmaceuticals (NASDAQ:VRTX), a global biotechnology company with a market capitalization of $119.1 billion known for its transformative cystic fibrosis (CF) treatments, finds itself at a ...
The star joined forces with Dermot Bannon to achieve his goal of opening a home away from home for the families of cystic ...
Children whose cystic fibrosis is caused by a rare gene variant are excluded from a new treatment which could potentially ...
RTE Room to Improve viewers were moved to tears tonight as an old home was transformed into something “amazing” for Cystic ...
FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.
Julian throughout his life has witnessed the low moments for patients while in hospital. For families to visit and spend time ...
Devyser has secured a tender for its cystic fibrosis NGS test, Devyser CFTR. The tender with Policlinico di Bari is valid for five years with an estimated total order value up to 5.4 million SEK "This ...
A Wicklow mother is among a concerned group of parents who are calling for individual trials of the modulator therapies for ...
A new EMA approval has expanded the use of Vertex Pharma’s cystic fibrosis therapy Symkevi to ... with Vertex' Kalydeco (ivacaftor) in patients ages six years and older who have two copies ...